Global Vaccines Market Size By Age Group (Pediatric, Adult), By Technology (Conjugate, Attenuated, Inactivated, Recombinant, Toxoid), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus), Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Nov 2017  |  Report ID: GMI2186  |  Authors: Sumant Ugalmugale, Rupali Swain

Report Format: PDF   |   Pages: 192   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1.  Methodology

1.1. Methodology 

1.2. Market definitions                      

1.3. Forecast parameters                  

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Global vaccines industry 3600 synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Age group trends

2.1.3. Disease trends

2.1.4. Technology trends

2.1.5. Regional trends

Chapter 3. Vaccines Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 – 2025

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1.  Increasing government funding for vaccine development

3.3.1.2.  Increasing vaccines R&D in developed nations

3.3.1.3.  Increasing disease prevalence in underdeveloped countries

3.3.1.4.  Growing incidences of cancer & HIV in Asia Pacific

3.3.2. Industry pitfalls & challenges

3.3.2.1.  High cost of vaccine storage and transportation

3.3.2.2.  Stringent regulations for the approval of vaccines in developed nations

3.3.2.3.  Drug-development hurdles

3.4. Growth potential analysis

3.4.1. By age group

3.4.2. By technology

3.4.3. By disease

3.5. Regulatory landscape

3.5.1. U.S

3.5.2. Europe

3.5.3. Asia Pacific

3.6. Reimbursement scenario

3.6.1. U.S

3.6.2. Europe

3.7. Technology landscape

3.8. Pricing analysis

3.9. Pipeline product analysis

3.9.1. Malaria

3.9.2. HIV

3.9.3. Zika

3.9.4. Ebola

3.10. Porter’s analysis

3.11.        Company market share analysis, 2017

3.11.1.  Strategy dashboard

3.12. PESTEL analysis

Chapter 4. Vaccines Market, By Age group

4.1. Key segment trends

4.2. Pediatric

4.2.1. Market estimates and forecast, by region, 2014 - 2025

4.3. Adult

4.3.1. Market estimates and forecast, by region, 2014 - 2025

Chapter 5.  Vaccines Market, By Technology

5.1. Key segment trends

5.2. Attenuated

5.2.1. Market estimates and forecast, by region, 2014 - 2025

5.3. Toxoid

5.3.1. Market estimates and forecast, by region, 2014 – 2025

5.4. Conjugate

5.4.1. Market estimates and forecast, by region, 2014 – 2025

5.5. Inactivated & subunit

5.5.1. Market estimates and forecast, by region, 2014 – 2025

5.6. Recombinant

5.6.1. Market estimates and forecast, by region, 2014 – 2025

5.7. Others

5.7.1. Market estimates and forecast, by region, 2014 – 2025

Chapter 6.     Vaccines Market, By Disease

6.1. Key segment trends

6.2. Cancer

6.2.1. Market estimates and forecast, by region, 2014 – 2025

6.3. Hepatitis

6.3.1. Market estimates and forecast, by region, 2014 – 2025

6.4. Pneumococcal disease

6.4.1. Market estimates and forecast, by region, 2014 – 2025

6.5. DTP

6.5.1. Market estimates and forecast, by region, 2014 – 2025

6.6. Dengue

6.6.1. Market estimates and forecast, by region, 2014 – 2025

6.7. Influenza

6.7.1. Market estimates and forecast, by region, 2014 – 2025

6.8. Human papilloma virus

6.8.1. Market estimates and forecast, by region, 2014 – 2025

6.9. Meningococcal disease

6.9.1. Market estimates and forecast, by region, 2014 – 2025

6.10. Polio

6.10.1.  Market estimates and forecast, by region, 2014 – 2025

6.11. Rotavirus

6.11.1.  Market estimates and forecast, by region, 2014 – 2025

6.12. Others

6.12.1.  Market estimates and forecast, by region, 2014 – 2025

Chapter 7. Vaccines Market, By Region

7.1. Key regional trends

7.2. North America

7.2.1. Market estimates and forecast, by country, 2014 – 2025

7.2.2. Market estimates and forecast, by age group, 2014 – 2025

7.2.3. Market estimates and forecast, by technology, 2014 – 2025

7.2.4. Market estimates and forecast, by disease, 2014 – 2025

7.2.5. U.S.

7.2.5.1. Market estimates and forecast, by age group, 2014 – 2025

7.2.5.2. Market estimates and forecast, by technology, 2014 – 2025

7.2.5.3. Market estimates and forecast, by disease, 2014 – 2025

7.2.6. Canada

7.2.6.1. Market estimates and forecast, by age group, 2014 – 2025

7.2.6.2. Market estimates and forecast, by technology, 2014 – 2025

7.2.6.3. Market estimates and forecast, by disease, 2014 – 2025

7.3. Europe

7.3.1. Market estimates and forecast, by country, 2014 – 2025

7.3.2. Market estimates and forecast, by age group, 2014 – 2025

7.3.3.    Market estimates and forecast, by technology, 2014 – 2025

7.3.4. Market estimates and forecast, by disease, 2014 – 2025

7.3.5. Germany

7.3.5.1. Market estimates and forecast, by age group, 2014 – 2025

7.3.5.2. Market estimates and forecast, by technology, 2014 – 2025

7.3.5.3. Market estimates and forecast, by disease, 2014 – 2025

7.3.6. UK

7.3.6.1. Market estimates and forecast, by age group, 2014 – 2025

7.3.6.2. Market estimates and forecast, by technology, 2014 – 2025

7.3.6.3. Market estimates and forecast, by disease, 2014 – 2025

7.3.7. Italy

7.3.7.1. Market estimates and forecast, by age group, 2014 – 2025

7.3.7.2. Market estimates and forecast, by technology, 2014 – 2025

7.3.7.3. Market estimates and forecast, by disease, 2014 – 2025

7.3.8. France

7.3.8.1. Market estimates and forecast, by age group, 2014 – 2025

7.3.8.2. Market estimates and forecast, by technology, 2014 – 2025

7.3.8.3. Market estimates and forecast, by disease, 2014 – 2025

7.3.9. Spain

7.3.9.1. Market estimates and forecast, by age group, 2014 – 2025

7.3.9.2. Market estimates and forecast, by technology, 2014 – 2025

7.3.9.3. Market estimates and forecast, by disease, 2014 – 2025

7.3.10.  Russia

7.3.10.1.  Market estimates and forecast, by age group, 2014 – 2025

7.3.10.2.  Market estimates and forecast, by technology, 2014 – 2025

7.3.10.3.  Market estimates and forecast, by disease, 2014 – 2025

7.4. Asia Pacific

7.4.1. Market estimates and forecast, by country, 2014 – 2025

7.4.2. Market estimates and forecast, by age group, 2014 – 2025

7.4.3. Market estimates and forecast, by technology, 2014 – 2025

7.4.4. Market estimates and forecast, by disease, 2014 – 2025

7.4.5. China

7.4.5.1. Market estimates and forecast, by age group, 2014 – 2025

7.4.5.2. Market estimates and forecast, by technology, 2014 – 2025

7.4.5.3. Market estimates and forecast, by disease, 2014 – 2025

7.4.6. India

7.4.6.1. Market estimates and forecast, by age group, 2014 – 2025

7.4.6.2. Market estimates and forecast, by technology, 2014 – 2025

7.4.6.3. Market estimates and forecast, by disease, 2014 – 2025

7.4.7. Japan

7.4.7.1. Market estimates and forecast, by age group, 2014 – 2025

7.4.7.2. Market estimates and forecast, by technology, 2014 – 2025

7.4.7.3. Market estimates and forecast, by disease, 2014 – 2025

7.4.8. South Korea

7.4.8.1. Market estimates and forecast, by age group, 2014 – 2025

7.4.8.2. Market estimates and forecast, by technology, 2014 – 2025

7.4.8.3. Market estimates and forecast, by disease, 2014 – 2025

7.4.9. Australia

7.4.9.1. Market estimates and forecast, by age group, 2014 – 2025

7.4.9.2. Market estimates and forecast, by technology, 2014 – 2025

7.4.9.3. Market estimates and forecast, by disease, 2014 – 2025

7.5. Latin America

7.5.1. Market estimates and forecast, by country, 2014 – 2025

7.5.2. Market estimates and forecast, by age group, 2014 – 2025

7.5.3. Market estimates and forecast, by technology, 2014 – 2025

7.5.4. Market estimates and forecast, by disease, 2014 – 2025

7.5.5. Brazil

7.5.5.1. Market estimates and forecast, by age group, 2014 – 2025

7.5.5.2. Market estimates and forecast, by technology, 2014 – 2025

7.5.5.3. Market estimates and forecast, by disease, 2014 – 2025

7.5.6. Mexico

7.5.6.1. Market estimates and forecast, by age group, 2014 – 2025

7.5.6.2. Market estimates and forecast, by technology, 2014 – 2025

7.5.6.3. Market estimates and forecast, by disease, 2014 – 2025

7.5.7. Argentina

7.5.7.1. Market estimates and forecast, by age group, 2014 – 2025

7.5.7.2. Market estimates and forecast, by technology, 2014 – 2025

7.5.7.3. Market estimates and forecast, by disease, 2014 – 2025

7.6. Middle East & Africa

7.6.1. Market estimates and forecast, by country, 2014 – 2025

7.6.2. Market estimates and forecast, by age group, 2014 – 2025

7.6.3.    Market estimates and forecast, by technology, 2014 – 2025

7.6.4. Market estimates and forecast, by disease, 2014 – 2025

7.6.5. South Africa

7.6.5.1. Market estimates and forecast, by age group, 2014 – 2025

7.6.5.2. Market estimates and forecast, by technology, 2014 – 2025

7.6.5.3. Market estimates and forecast, by disease, 2014 – 2025

7.6.6. Saudi Arabia

7.6.6.1. Market estimates and forecast, by age group, 2014 – 2025

7.6.6.2. Market estimates and forecast, by technology, 2014 – 2025

7.6.6.3. Market estimates and forecast, by disease, 2014 – 2025

7.6.7. UAE

7.6.7.1. Market estimates and forecast, by age group, 2014 – 2025

7.6.7.2. Market estimates and forecast, by technology, 2014 – 2025

7.6.7.3. Market estimates and forecast, by disease, 2014 – 2025

7.6.8. Qatar

7.6.8.1. Market estimates and forecast, by age group, 2014 – 2025

7.6.8.2. Market estimates and forecast, by technology, 2014 – 2025

7.6.8.3. Market estimates and forecast, by disease, 2014 – 2025

7.6.9. Egypt

7.6.9.1. Market estimates and forecast, by age group, 2014 – 2025

7.6.9.2. Market estimates and forecast, by technology, 2014 – 2025

7.6.9.3. Market estimates and forecast, by disease, 2014 – 2025

Chapter 8.  Company Profiles

8.1. Abbott

8.1.1. Business overview

8.1.2. Financial data

8.1.3. Product landscape

8.1.4. Strategic outlook

8.1.5. SWOT analysis

8.2. Astellas Pharma, Inc.

8.2.1. Business overview

8.2.2. Financial data

8.2.3. Product landscape

8.2.4. Strategic outlook

8.2.5. SWOT analysis

8.3. AstraZeneca

8.3.1. Business overview

8.3.2. Financial data

8.3.3. Product landscape

8.3.4. Strategic outlook

8.3.5. SWOT analysis

8.4. Bristol-Myers Squibb

8.4.1. Business overview

8.4.2. Financial data

8.4.3. Product landscape

8.4.4. Strategic outlook

8.4.5. SWOT analysis

8.5. CSL Limited

8.5.1. Business overview

8.5.2. Financial data

8.5.3. Product landscape

8.5.4. Strategic outlook

8.5.5. SWOT analysis

8.6. Emergent BioSolutions, Inc.

8.6.1. Business overview

8.6.2. Financial data

8.6.3. Product landscape

8.6.4. Strategic outlook

8.6.5. SWOT analysis

8.7. GlaxoSmithKline

8.7.1. Business overview

8.7.2. Financial data

8.7.3. Product landscape

8.7.4. Strategic outlook

8.7.5. SWOT analysis

8.8. Johnson & Johnson

8.8.1. Business overview

8.8.2. Financial data

8.8.3. Product landscape

8.8.4. Strategic outlook

8.8.5. SWOT analysis

8.9. Merck & Co.

8.9.1. Business overview

8.9.2. Financial data

8.9.3. Product landscape

8.9.4. Strategic outlook

8.9.5. SWOT analysis

8.10. Novavax, Inc.

8.10.1.  Business overview

8.10.2.  Financial data

8.10.3.  Product landscape

8.10.4.  Strategic outlook

8.10.5.  SWOT analysis

8.11. Pfizer

8.11.1.  Business overview

8.11.2.  Financial data

8.11.3.  Product landscape

8.11.4.  Strategic outlook

8.11.5.  SWOT analysis

8.12. Sanofi Pasteur

8.12.1.  Business overview

8.12.2.  Financial data

8.12.3.  Product landscape

8.12.4.  Strategic outlook

8.12.5.  SWOT analysis

 

 

Data Tables

TABLE 1    Vaccines industry 3600 synopsis, 2014 – 2025

TABLE 2    Global vaccines market, 2014 – 2018 (USD Million)

TABLE 3    Global vaccines market, 2019 – 2025 (USD Million)

TABLE 4    Global vaccines market, by age group, 2014 - 2018 (USD Million)

TABLE 5    Global vaccines market, by age group, 2019 - 2025 (USD Million)

TABLE 6    Global vaccines market, by technology, 2014 – 2018 (USD Million)

TABLE 7    Global vaccines market, by technology, 2019 – 2025 (USD Million)

TABLE 8    Global vaccines market, by disease, 2014 – 2018 (USD Million)

TABLE 9    Global vaccines market, by disease, 2019 – 2025 (USD Million)

TABLE 10    Global vaccines market, by region, 2014 – 2018 (USD Million)

TABLE 11    Global vaccines market, by region, 2019 – 2025 (USD Million)

TABLE 12    Industry impact forces

TABLE 13    Pediatric vaccine market size, by region, 2014 – 2018 (USD Million)

TABLE 14    Pediatric vaccine market size, by region, 2019 – 2025 (USD Million)

TABLE 15    Adult vaccine market size, by region, 2014 – 2018 (USD Million)

TABLE 16    Adult vaccine market size, by region, 2019 – 2025 (USD Million)

TABLE 17    Conjugate vaccine market size, by region, 2014 – 2018 (USD Million)

TABLE 18    Conjugate vaccine market size, by region, 2019 – 2025 (USD Million)

TABLE 19    Attenuated vaccine market size, by region, 2014 – 2018 (USD Million)

TABLE 20    Attenuated vaccine market size, by region, 2019 – 2025 (USD Million)

TABLE 21    Inactivated & subunit vaccine market size, by region, 2014 – 2018 (USD Million)

TABLE 22    Inactivated & subunit vaccine market size, by region, 2019 – 2025 (USD Million)

TABLE 23    Recombinant vaccine market size, by region, 2014 – 2018 (USD Million)

TABLE 24    Recombinant vaccine market size, by region, 2019 – 2025 (USD Million)

TABLE 25    Toxoid vaccine market size, by region, 2014 – 2018 (USD Million)

TABLE 26    Toxoid vaccine market size, by region, 2019 – 2025 (USD Million)

TABLE 27    Others market size, by region, 2014 – 2018 (USD Million)

TABLE 28    Others market size, by region, 2019 – 2025 (USD Million)

TABLE 29    Cancer market size, by region, 2014 – 2018 (USD Million)

TABLE 30    Cancer market size, by region, 2019 – 2025 (USD Million)

TABLE 31    Hepatitis market size, by region, 2014 – 2018 (USD Million)

TABLE 32    Hepatitis market size, by region, 2019 – 2025 (USD Million)

TABLE 33    Pneumococcal disease market size, by region, 2014 – 2018 (USD Million)

TABLE 34    Pneumococcal disease market size, by region, 2019 – 2025 (USD Million)

TABLE 35    DTP market size, by region, 2014 – 2018 (USD Million)

TABLE 36    DTP market size, by region, 2019 – 2025 (USD Million)

TABLE 37    Dengue market size, by region, 2014 – 2018 (USD Million)

TABLE 38    Dengue market size, by region, 2019 – 2025 (USD Million)

TABLE 39    Influenza market size, by region, 2014 – 2018 (USD Million)

TABLE 40    Influenza market size, by region, 2019 – 2025 (USD Million)

TABLE 41    Human papillomavirus market size, by region, 2014 – 2018 (USD Million)

TABLE 42    Human papillomavirus market size, by region, 2019 – 2025 (USD Million)

TABLE 43    Meningococcal disease market size, by region, 2014 – 2018 (USD Million)

TABLE 44    Meningococcal disease market size, by region, 2019 – 2025 (USD Million)

TABLE 45    Polio market size, by region, 2014 – 2018 (USD Million)

TABLE 46    Polio market size, by region, 2019 – 2025 (USD Million)

TABLE 47    Rotavirus market size, by region, 2014 – 2018 (USD Million)

TABLE 48    Rotavirus market size, by region, 2019 – 2025 (USD Million)

TABLE 49    Others market size, by region, 2014 – 2018 (USD Million)

TABLE 50    Others market size, by region, 2019 – 2025 (USD Million)

TABLE 51    North America vaccines market size, by country, 2014 - 2018 (USD Million)

TABLE 52    North America vaccines market size, by country, 2019 - 2025 (USD Million)

TABLE 53    North America vaccines market size, by age group, 2014 - 2018 (USD Million)

TABLE 54    North America vaccines market size, by age group, 2019 - 2025 (USD Million)

TABLE 55    North America vaccines market size, by technology, 2014 - 2018 (USD Million)

TABLE 56    North America vaccines market size, by technology, 2019 - 2025 (USD Million)

TABLE 57    North America vaccines market size, by disease, 2014 - 2018 (USD Million)

TABLE 58    North America vaccines market size, by disease, 2019 - 2025 (USD Million)

TABLE 59    U.S. vaccines market size, by age group, 2014 - 2018 (USD Million)

TABLE 60    U.S. vaccines market size, by age group, 2019 - 2025 (USD Million)

TABLE 61    U.S. vaccines market size, by technology, 2014 - 2018 (USD Million)

TABLE 62    U.S. vaccines market size, by technology, 2019 - 2025 (USD Million)

TABLE 63    U.S. vaccines market size, by disease, 2014 - 2018 (USD Million)

TABLE 64    U.S. vaccines market size, by disease, 2019 - 2025 (USD Million)

TABLE 65    Canada vaccines market size, by age group, 2014 - 2018 (USD Million)

TABLE 66    Canada vaccines market size, by age group, 2019 - 2025 (USD Million)

TABLE 67    Canada vaccines market size, by technology, 2014 - 2018 (USD Million)

TABLE 68    Canada vaccines market size, by technology, 2019 - 2025 (USD Million)

TABLE 69    Canada vaccines market size, by disease, 2014 - 2018 (USD Million)

TABLE 70    Canada vaccines market size, by disease, 2019 - 2025 (USD Million)

TABLE 71    Europe vaccines market size, by country, 2014 - 2018 (USD Million)

TABLE 72    Europe vaccines market size, by country, 2019 - 2025 (USD Million)

TABLE 73    Europe vaccines market size, by age group, 2014 - 2018 (USD Million)

TABLE 74    Europe vaccines market size, by age group, 2019 - 2025 (USD Million)

TABLE 75    Europe vaccines market size, by technology, 2014 - 2018 (USD Million)

TABLE 76    Europe vaccines market size, by technology, 2019 - 2025 (USD Million)

TABLE 77    Europe vaccines market size, by disease, 2014 - 2018 (USD Million)

TABLE 78    Europe vaccines market size, by disease, 2019 - 2025 (USD Million)

TABLE 79    Germany vaccines market size, by age group, 2014 - 2018 (USD Million)

TABLE 80    Germany vaccines market size, by age group, 2019 - 2025 (USD Million)

TABLE 81    Germany vaccines market size, by technology, 2014 - 2018 (USD Million)

TABLE 82    Germany vaccines market size, by technology, 2019 - 2025 (USD Million)

TABLE 83    Germany vaccines market size, by disease, 2014 - 2018 (USD Million)

TABLE 84    Germany vaccines market size, by disease, 2019 - 2025 (USD Million)

TABLE 85    UK vaccines market size, by age group, 2014 - 2018 (USD Million)

TABLE 86    UK vaccines market size, by age group, 2019 - 2025 (USD Million)

TABLE 87    UK vaccines market size, by technology, 2014 - 2018 (USD Million)

TABLE 88    UK vaccines market size, by technology, 2019 - 2025 (USD Million)

TABLE 89    UK vaccines market size, by disease, 2014 - 2018 (USD Million)

TABLE 90    UK vaccines market size, by disease, 2019 - 2025 (USD Million)

TABLE 91    Italy vaccines market size, by age group, 2014 - 2018 (USD Million)

TABLE 92    Italy vaccines market size, by age group, 2019 - 2025 (USD Million)

TABLE 93    Italy vaccines market size, by technology, 2014 - 2018 (USD Million)

TABLE 94    Italy vaccines market size, by technology, 2019 - 2025 (USD Million)

TABLE 95    Italy vaccines market size, by disease, 2014 - 2018 (USD Million)

TABLE 96    Italy vaccines market size, by disease, 2019 - 2025 (USD Million)

TABLE 97    France vaccines market size, by age group, 2014 - 2018 (USD Million)

TABLE 98    France vaccines market size, by age group, 2019 - 2025 (USD Million)

TABLE 99    France vaccines market size, by technology, 2014 - 2018 (USD Million)

TABLE 100   France vaccines market size, by technology, 2019 - 2025 (USD Million)

TABLE 101   France vaccines market size, by disease, 2014 - 2018 (USD Million)

TABLE 102   France vaccines market size, by disease, 2019 - 2025 (USD Million)

TABLE 103   Spainvaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE104   Spainvaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE105   Spainvaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE106   Spainvaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE107   Spainvaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE108   Spainvaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE109   Russiavaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE110   Russiavaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE111   Russiavaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE112   Russiavaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE113   Russiavaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE114   Russiavaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE115   AsiaPacificvaccinesmarketsize,bycountry,2014-2018(USDMillion)

TABLE116   AsiaPacificvaccinesmarketsize,bycountry,2019-2025(USDMillion)

TABLE117   AsiaPacificvaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE118   AsiaPacificvaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE119   AsiaPacificvaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE120   AsiaPacificvaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE121   AsiaPacificvaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE122   AsiaPacificvaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE123   Chinavaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE124   Chinavaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE125   Chinavaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE126   Chinavaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE127   Chinavaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE128   Chinavaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE129   Indiavaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE130   Indiavaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE131   Indiavaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE132   Indiavaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE133   Indiavaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE134   Indiavaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE135   Japanvaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE136   Japanvaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE137   Japanvaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE138   Japanvaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE139   Japanvaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE140   Japanvaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE141   SouthKoreavaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE142   SouthKoreavaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE143   SouthKoreavaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE144   SouthKoreavaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE145   SouthKoreavaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE146   SouthKoreavaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE147   Australiavaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE148   Australiavaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE149   Australiavaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE150   Australiavaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE151   Australiavaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE152   Australiavaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE153   LatinAmericavaccinesmarketsize,bycountry,2014-2018(USDMillion)

TABLE154   LatinAmericavaccinesmarketsize,bycountry,2019-2025(USDMillion)

TABLE155   LatinAmericavaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE156   LatinAmericavaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE157   LatinAmericavaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE158   LatinAmericavaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE159   LatinAmericavaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE160   LatinAmericavaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE161   Brazilvaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE162   Brazilvaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE163   Brazilvaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE164   Brazilvaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE165   Brazilvaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE166   Brazilvaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE167   Mexicovaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE168   Mexicovaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE169   Mexicovaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE170   Mexicovaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE171   Mexicovaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE172   Mexicovaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE173   Argentinavaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE174   Argentinavaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE175   Argentinavaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE176   Argentinavaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE177   Argentinavaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE178   Argentinavaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE179   MEAvaccinesmarketsize,bycountry,2014-2018(USDMillion)

TABLE180   MEAvaccinesmarketsize,bycountry,2019-2025(USDMillion)

TABLE181   MEAvaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE182   MEAvaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE183   MEAvaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE184   MEAvaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE185   MEAvaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE186   MEAvaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE187   SouthAfricavaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE188   SouthAfricavaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE189   SouthAfricavaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE190   SouthAfricavaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE191   SouthAfricavaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE192   SouthAfricavaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE193   SaudiArabiavaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE194   SaudiArabiavaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE195   SaudiArabiavaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE196   SaudiArabiavaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE197   SaudiArabiavaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE198   SaudiArabiavaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE199   UAEvaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE200   UAEvaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE201   UAEvaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE202   UAEvaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE203   UAEvaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE204   UAEvaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE205   Qatarvaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE206   Qatarvaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE207   Qatarvaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE208   Qatarvaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE209   Qatarvaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE210   Qatarvaccinesmarketsize,bydisease,2019-2025(USDMillion)

TABLE211   Egyptvaccinesmarketsize,byagegroup,2014-2018(USDMillion)

TABLE212   Egyptvaccinesmarketsize,byagegroup,2019-2025(USDMillion)

TABLE213   Egyptvaccinesmarketsize,bytechnology,2014-2018(USDMillion)

TABLE214   Egyptvaccinesmarketsize,bytechnology,2019-2025(USDMillion)

TABLE215   Egyptvaccinesmarketsize,bydisease,2014-2018(USDMillion)

TABLE216   Egyptvaccinesmarketsize,bydisease,2019-2025(USDMillion)

   

Charts&Figures

FIG.1   Industrysegmentation

FIG.2   Globalvaccinesmarket,2014-2025(USDMillion)

FIG.3   Growthpotentialanalysis,agegroup

FIG.4   Growthpotentialanalysis,bytechnology

FIG.5   Growthpotentialanalysis,bydiseases

FIG.6   Porter’sanalysis

FIG.7   Companyshareanalysis,2017

FIG.8   Strategydashboard

FIG.9   PESTELanalysis

   

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust


  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X